Question 1

What is IXAZOMIB used for?

Accepted Answer

IXAZOMIB (brand name NINLARO) is a Other indicated for 14.3) ] ..

Question 2

How does IXAZOMIB work?

Accepted Answer

IXAZOMIB works through the following mechanism: 12.1 Mechanism of Action Ixazomib is a reversible proteasome inhibitor. Ixazomib preferentially binds and inhibits the chymotrypsin-like activity of the beta 5 subunit of the 20S proteasome. Ixazomib induced apoptosis of multiple myeloma cell lines in vitro. Ixazomib demonstrated in vitro cytotoxicity against myeloma cells from patients who had relapsed after multiple prior therapies, including bortezomib, lenalidomide, and dexamethasone. The combination of ixazomib and lenalidomide demonstrated synergistic cytotoxic effects in multiple myeloma cell lines. In vivo, ixazomib demonstrated antitumor activity in a mouse multiple myeloma tumor xenograft model..

Question 3

What are the most common side effects of IXAZOMIB?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for IXAZOMIB. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is IXAZOMIB the same as NINLARO?

Accepted Answer

NINLARO is a brand name for IXAZOMIB. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

IXAZOMIB

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations